Angiographic late lumen loss revisited: impact on long-term target lesion revascularization-Reference-Cited by-同舟云学术

Angiographic late lumen loss revisited: impact on long-term target lesion revascularization

Published:2018-08-16 Issue:36 Volume:39 Page:3381-3389
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:

Author:

Asano Taku¹²,Serruys Patrick W³,Collet Carlos¹⁴,Miyazaki Yosuke⁵,Takahashi Kuniaki¹,Chichareon Ply¹,Katagiri Yuki¹,Modolo Rodrigo¹,Tenekecioglu Erhan⁵,Morel Marie-Angèle⁶,Garg Scot⁷,Wykrzykowska Joanna¹,Piek Jan J¹,Sabate Manel⁸,Morice Marie-Claude⁹,Chevalier Bernard⁹,Windecker Stephan¹⁰,Onuma Yoshinobu⁵⁶

Affiliation:

1. Academic Medical Center, University of Amsterdam, Meibergdreef 9, AZ Amsterdam, The Netherlands

2. St. Luke's International Hospital, 9-1 Akashicho, Chūō, Tokyo, Japan

3. NHLI, Imperial College London, Dovehouse Street, Chelsea, London, UK

4. Department of Cardiology, Universitair Ziekenhuis Brussel, Avenue du Laerbeek 101, Jette, Belgium

5. ThoraxCenter, Erasmus Medical Center, Doctor Molewaterplein 40, GD Rotterdam, The Netherlands

6. Cardialysis, Westblaak 98, KM Rotterdam, The Netherlands

7. East Lancashire Hospitals NHS Trust, Casterton Ave, Burnley, UK

8. Cardiovascular Institute, Hospital Clinic, IDIBAPS, University of Barcelona, Carrer del Rosselló, 149, Barcelona, Spain

9. Institut Cardiovasculaire Paris Sud, 6 Avenue du Noyer Lambert, Massy, France

10. Bern University Hospital, Freiburgstrasse 18, Bern, Switzerland

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartj/article-pdf/39/36/3381/25817367/ehy436.pdf

Reference37 articles.

1. Prevention of restenosis after percutaneous transluminal coronary angioplasty with thromboxane A2-receptor blockade. A randomized, double-blind, placebo-controlled trial. Coronary Artery Restenosis Prevention on Repeated Thromboxane-Antagonism Study (CARPORT);Serruys;Circulation,1991

2. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group;Serruys;. N Engl J Med,1994

3. Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial;Serruys;Lancet,2016

4. Robustness of late lumen loss in discriminating drug-eluting stents across variable observational and randomized trials;Mauri;Circulation,2005

5. Angiographic surrogate end points in drug-eluting stent trials: a systematic evaluation based on individual patient data from 11 randomized, controlled trials;Pocock;J Am Coll Cardiol,2008

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison Between Drug-Coated Balloon and Stents in Large De Novo Coronary Artery Disease: A Systematic Review and Meta-Analysis of RCT Data;Cardiovascular Drugs and Therapy;2024-01-25

2. First randomised controlled trial comparing the sirolimus-eluting bioadaptor with the zotarolimus-eluting drug-eluting stent in patients with de novo coronary artery lesions: 12-month clinical and imaging data from the multi-centre, international, BIODAPTOR-RCT;eClinicalMedicine;2023-11

3. Is it time for a retinoic acid-eluting stent or retinoic acid-coated balloon? Insights from experimental studies of systemic and local delivery of retinoids;Hellenic Journal of Cardiology;2023-08

4. Safety and performance of the third-generation drug-eluting resorbable coronary magnesium scaffold system in the treatment of subjects with de novo coronary artery lesions: 6-month results of the prospective, multicenter BIOMAG-I first-in-human study;eClinicalMedicine;2023-05

5. Third-Generation Sirolimus‐Eluting Bioresorbable Tyrocore Scaffold Implantation in Patients with ST‐Segment Elevation Myocardial Infarction: Baseline and 6-Month OCT and Clinical Outcomes—a FANTOM STEMI Pilot Study;Cardiovascular Drugs and Therapy;2023-01-14